Article
Multiomics analysis of tumor mutational burden across cancer types
1 Jan 2021
Abstract excerpt
Whether tumor mutational burden (TMB) is related to improved survival outcomes or the promotion of immunotherapy in various malignant tumors remains controversial, and we lack a comprehensive understanding of TMB across cancers. Based on the data obtained from The Cancer Genome Atlas (TCGA), we conducted a multiomics analysis of TMB across 21 cancer types to identify characteristics related to TMB and determine...
Topics
Join the communities discussing this publication.
